MedPath

WAKE FOREST UNIVERSITY

WAKE FOREST UNIVERSITY logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1834-02-03
Employees
5K
Market Cap
-
Website
http://www.wfu.edu

Clinical Trials

116

Active:2
Completed:79

Trial Phases

6 Phases

Early Phase 1:2
Phase 1:4
Phase 2:11
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (92 trials with phase data)• Click on a phase to view related trials

Not Applicable
52 (56.5%)
Phase 4
19 (20.7%)
Phase 2
11 (12.0%)
Phase 1
4 (4.3%)
Phase 3
4 (4.3%)
Early Phase 1
2 (2.2%)

A Mobile Intervention to Reduce Pain and Improve Health-III

Phase 2
Recruiting
Conditions
Chronic Pain
Osteoarthritis
Obesity and Overweight
Inactivity
First Posted Date
2024-10-02
Last Posted Date
2025-07-04
Lead Sponsor
Wake Forest University
Target Recruit Count
200
Registration Number
NCT06623669
Locations
🇺🇸

Wake Forest University, Winston Salem, North Carolina, United States

Probiotic Effect on Dietary Nitrate to Plasma Nitrite Production ( OPEDNPN )

Not Applicable
Recruiting
Conditions
Cardiovascular Diseases
Diabetes
Hypertension
First Posted Date
2024-04-19
Last Posted Date
2024-07-19
Lead Sponsor
Wake Forest University
Target Recruit Count
20
Registration Number
NCT06375694
Locations
🇺🇸

Wake Forest University, Winston-Salem, North Carolina, United States

The Osteoarthritis Prevention Study

Not Applicable
Recruiting
Conditions
Osteoarthritis, Knee
First Posted Date
2023-07-14
Last Posted Date
2024-08-21
Lead Sponsor
Wake Forest University
Target Recruit Count
1230
Registration Number
NCT05946044
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

🇺🇸

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

🇺🇸

Wake Forest University, Winston-Salem, North Carolina, United States

and more 1 locations

Lifestyle Interventions for Vitality and Empowerment in Seniors

Not Applicable
Not yet recruiting
Conditions
Cognitive Change
First Posted Date
2022-11-30
Last Posted Date
2022-11-30
Lead Sponsor
Wake Forest University
Target Recruit Count
30
Registration Number
NCT05631106

Effect of Beet-root Juice and PBM Treatments on Muscle Fatigue

Not Applicable
Recruiting
Conditions
Healthy Aging
Health Care Utilization
First Posted Date
2022-10-27
Last Posted Date
2024-03-20
Lead Sponsor
Wake Forest University
Target Recruit Count
10
Registration Number
NCT05596474
Locations
🇺🇸

Wake Forest Univesity, Winston-Salem, North Carolina, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 24
  • Next

News

Intensive Blood Pressure Control Shows Long-Term Cognitive Benefits in Landmark SPRINT Trial

Intensive blood pressure management for 3.3 years significantly reduces the risk of mild cognitive impairment and dementia in adults with hypertension.

GLP-1 and SGLT2 Inhibitors Show Promise in Preventing Secondary Cardiovascular Events in Stroke Survivors

• A new study suggests GLP-1 receptor agonists and SGLT2 inhibitors may significantly reduce the risk of heart attacks and death in stroke survivors. • SGLT2 inhibitors were associated with a 67% lower risk of second strokes, offering a potential preventative measure for recurrent events. • The research highlights the potential of these diabetes and weight loss drugs in preventing further cardiovascular events in individuals who have experienced ischemic stroke. • Findings indicate a substantial reduction in death rates among stroke survivors taking these medications, from 54% to 11.8%.

© Copyright 2025. All Rights Reserved by MedPath